alexa Identification of a Chemoresistant “Oxidativ
ISSN: 2157-7633

Journal of Stem Cell Research & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Identification of a Chemoresistant “Oxidative State-Low” Leukemic Subpopulation in CD34+ Human Acute Myeloid Leukemia

Ioannis Kotsianidis1*, Dimitra Kokkinou2, Elena K Siapati3, Paraskevi Miltiades1, Eleftheria Lamprianidou1, George Vassilopoulos3,4, Nicholas C Zoumpos1 and Alexandros Spyridonidis1

1Department of Hematology, Democritus University of Thrace, Medical school, Greece

2Division of Hematology, University Hospital of Patras, Greece

3Division of Genetics and Gene Therapy, Academy of Athens, Greece

4Division of Hematology, University Hospital of Thessaly, Greece

*Corresponding Author:
Ioannis Kotsianidis, MD, PhD
Department of Hematology
Democritus University of Thrace
Medical School, Dragana, Alexandroupolis 68100, Greece
Tel: +302551030320
Fax: +302551076154
E-mail: [email protected], [email protected]

Received date: August 04, 2014; Accepted date: September 23, 2014; Published date: September 25, 2014

Citation: Kotsianidis I, Kokkinou D, Siapati EK, Miltiades P, Lamprianidou E, et al. (2014) Identification of a Chemoresistant “Oxidative State-Low” Leukemic Subpopulation in CD34+ Human Acute Myeloid Leukemia. J Stem Cell Res Ther 4:235. doi:10.4172/2157-7633.1000235

Copyright: © 2014 Kotsianidis I, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



 

Abstract

Objective: Both normal and malignant stem cells maintain lower levels of reactive oxygen species (ROS), but the redox state in acute myeloid leukemia (AML) has not been thoroughly characterized and the role of ROS in leukemogenesis is still unclear. Herein, we report the identification of a rare but distinct ROSlow subpopulation in primary CD34+ AML samples. Methods: We analysed the ROS state of a number of AML samples by flow cytometry using the redox-sensitive fluorescence dye 2’7;-dichlorodihydrofluorescein diacetate. We FACS-sorted the ROSlow cells and investigated their immunophenotype, in vivo engraftment potential as well as their ability to withstand chemotherapeutic treatment. Results: Compared to the total CD34+ cells the ROSlow subset contained significantly more CMP-like and less GMP-like progenitors and could establish leukemia in NOD/SCID mice. Additionally, ROSlow cells bore a chemoresistant phenotype as they were more quiescent than total CD34+ AML cells, and showed increased in vitro chemoresistance and markedly higher GM-CSF-induced phosphorylation of STAT5. Conclusions: Thus, the ROSlow subpopulation arises as a novel candidate for cell-specific therapeutic targeting in AML. Further studies will help to ascertain the exact role of the ROSlow subset in the pathobiology and clinical management of AML.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords